| Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? F Davnall, CSP Yip, G Ljungqvist, M Selmi, F Ng, B Sanghera, ... Insights into imaging 3, 573-589, 2012 | 963 | 2012 |
| Are pretreatment 18F-FDG PET tumor textural features in non–small cell lung cancer associated with response and survival after chemoradiotherapy? GJR Cook, C Yip, M Siddique, V Goh, S Chicklore, A Roy, P Marsden, ... Journal of nuclear medicine 54 (1), 19-26, 2013 | 465 | 2013 |
| Imaging body composition in cancer patients: visceral obesity, sarcopenia and sarcopenic obesity may impact on clinical outcome C Yip, C Dinkel, A Mahajan, M Siddique, GJR Cook, V Goh Insights into imaging 6, 489-497, 2015 | 265 | 2015 |
| Concurrent chemo-radiation with or without induction gemcitabine, carboplatin, and paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma T Tan, WT Lim, KW Fong, SL Cheah, YL Soong, MK Ang, QS Ng, D Tan, ... International Journal of Radiation Oncology* Biology* Physics 91 (5), 952-960, 2015 | 236 | 2015 |
| Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer C Yip, V Goh, A Davies, J Gossage, R Mitchell-Hay, O Hynes, N Maisey, ... European radiology 24, 998-1005, 2014 | 231 | 2014 |
| Primary esophageal cancer: heterogeneity as potential prognostic biomarker in patients treated with definitive chemotherapy and radiation therapy C Yip, D Landau, R Kozarski, B Ganeshan, R Thomas, A Michaelidou, ... Radiology 270 (1), 141-148, 2014 | 215 | 2014 |
| Radiomics in PET: principles and applications GJR Cook, M Siddique, BP Taylor, C Yip, S Chicklore, V Goh Clinical and Translational Imaging 2, 269-276, 2014 | 154 | 2014 |
| Combinational immunotherapy for hepatocellular carcinoma: radiotherapy, immune checkpoint blockade and beyond YH Lee, D Tai, C Yip, SP Choo, V Chew Frontiers in immunology 11, 568759, 2020 | 122 | 2020 |
| Assessment of changes in tumor heterogeneity following neoadjuvant chemotherapy in primary esophageal cancer C Yip, F Davnall, R Kozarski, DB Landau, GJR Cook, P Ross, R Mason, ... Diseases of the Esophagus 28 (2), 172-179, 2015 | 99 | 2015 |
| Molecular imaging of hypoxia in non-small-cell lung cancer C Yip, PJ Blower, V Goh, DB Landau, GJR Cook European journal of nuclear medicine and molecular imaging 42, 956-976, 2015 | 60 | 2015 |
| The role of new PET tracers for lung cancer TA Szyszko, C Yip, P Szlosarek, V Goh, GJR Cook Lung Cancer 94, 7-14, 2016 | 59 | 2016 |
| Co-registration of cone beam CT and planning CT in head and neck IMRT dose estimation: a feasible adaptive radiotherapy strategy C Yip, C Thomas, A Michaelidou, D James, R Lynn, M Lei, ... The British Journal of Radiology 87 (1034), 20130532, 2014 | 28 | 2014 |
| Building motion models of lung tumours from cone-beam CT for radiotherapy applications J Martin, J McClelland, C Yip, C Thomas, C Hartill, S Ahmad, R O’Brien, ... Physics in Medicine & Biology 58 (6), 1809, 2013 | 27 | 2013 |
| Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer C Yip, GJR Cook, DB Landau, A Davies, V Goh Diseases of the Esophagus, 116-130, 2016 | 22 | 2016 |
| Outcomes of oral tongue cancer: does age matter? CSP Yip, TC Charn, JTS Wee, TWK Tan, C Goh, HK Tan, KW Fong Annals Academy of Medicine Singapore 39 (12), 897, 2010 | 18 | 2010 |
| Predicting outcomes for locally advanced rectal cancer treated with neoadjuvant chemoradiation with CT-based radiomics F Wang, BF Tan, SS Poh, TR Siow, FLWT Lim, CSP Yip, MLC Wang, ... Scientific Reports 12 (1), 6167, 2022 | 15 | 2022 |
| Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012; 3: 573–89 F Davnall, CS Yip, G Ljungqvist, M Selmi, F Ng, B Sanghera, B Ganeshan, ... Medline, 0 | 13 | |
| Challenges in imaging assessment following liver stereotactic body radiotherapy: pitfalls to avoid in clinical practice C Yip, GJR Cook, K Owczarczyk, V Goh Chinese Clinical Oncology 6 (Suppl 2), S11-S11, 2017 | 12 | 2017 |
| Imaging Tumor Response and Tumoral Heterogeneity in Non–Small Cell Lung Cancer Treated With Antiangiogenic Therapy: Comparison of the Prognostic Ability of RECIST 1.1, an … C Yip, N Tacelli, M Remy-Jardin, A Scherpereel, A Cortot, JJ Lafitte, ... Journal of Thoracic Imaging 30 (5), 300-307, 2015 | 10 | 2015 |
| Randomized phase III trial of concurrent chemoradiation with or without neoadjuvant gemcitabine, carboplatin, and paclitaxel in locally advanced nasopharyngeal cancer. T Tan, WT Lim, KW Fong, SL Cheah, YL Soong, MK Ang, QS Ng, ... Journal of Clinical Oncology 32 (15_suppl), 6003-6003, 2014 | 9 | 2014 |
